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CASE REPORT
SOFT TISSUE ABSCESS AND LYMPHADENITIS DUE TO Mycobacterium avium COMPLEX AS AN
EXPRESSION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER A SECOND
SCHEME OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
Marcelo CORTI(1), María F. VILLAFAÑE(1), Marta AMBROGGI(2), Mirna SAWICKI(3) & Elisa GANCEDO(3)
SUMMARY
Immune reconstitution inflammatory syndrome (IRIS) is an atypical and unexpected reaction related to highly active antiretroviral
therapy (HAART) in human immunodeficiency virus (HIV) infected patients. IRIS includes an atypical response to an opportunistic
pathogen (generally Mycobacterium tuberculosis, Mycobacterium avium complex, cytomegalovirus and herpes varicella-zoster),
in patients responding to HAART with a reduction of plasma viral load and evidence of immune restoration based on increase of
CD4+ T-cell count. We reported a case of a patient with AIDS which, after a first failure of HAART, developed a subcutaneous
abscess and supraclavicular lymphadenitis as an expression of IRIS due to Mycobacterium avium complex after starting a second
scheme of HAART.
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INTRODUCTION
The immune reconstitution inflammatory syndrome (IRIS) includes
several responses to preexisting opportunistic infections or tumors after
the restoration of immune function in human immunodeficiency virus
(HIV) infected patients receiving highly active antiretroviral therapy
(HAART)10,12. Before the HIV pandemic, IRIS was also described in
patients with chronic diseases such as leprosy and tuberculosis2,7,16.
Since the extending use of HAART, numerous papers describing
episodes of IRIS have been published in the medical literature5,17, and
IRIS became frequent (29% to 36%) in patients with history of
tuberculosis in the HAART era11.
We describe a patient, which developed a soft tissue abscess and a
focal supraclavicular lymphadenitis due to Mycobacterium avium
complex (MAC) after starting a second scheme of HAART.
CASE REPORT
A 32-year-old man, seropositive for human immunodeficiency virus
(HIV), with history of disseminated histoplasmosis and Mycobacterium
avium complex disseminated disease, was started on highly active
antiretroviral therapy (HAART) based on zidovudine plus lamivudine
plus nevirapine. At this moment, his plasma viral load was > 500,000
copies/mL (5.7 log10 copies/mL) and his CD4+ T-cell count was < of 50
cell/µL. He presented an initial good clinical, virological and
immunological response to this scheme of HAART. Three months later,
his plasma viral load was 32,814 copies/mL (4.52 log10 copies/mL)
and the CD4+ T-cell count was 361 cell/µL (21%). Six months later he
evidenced a virological failure with a rebound of the plasma viral load
(76,222 copies/mL/4.89 log10 copies/mL) and with a loss of CD4+ T-
cell count (289 cell/µL 20%).
At this moment, HAART was modified; then, he received a new
scheme based on abacavir plus didanosine plus saquinavir boosted with
ritonavir.
Two months later, with a plasma viral load of 424 copies/mL (2.63
log10 copies/mL) and CD4+ T-cell count of 348 cell/µL (18%), he
presented with fever, supraclavicular lymphadenitis (Fig. 1A) and pain
with tender and inflammatory swelling located at the right thigh.
Ultrasonography revealed the existence of a hypoechoic soft tissue
liquid collection of 79 x 31 x 26 mm of diameters consistent with an
abscess (Fig. 2). Aspiration of this mass and the supraclavicular
lymphadenopathy showed pus that contained scanty acid-fast bacilli.
Culture of this material was negative.
We supported the same scheme of HAART and antimycobacterial
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treatment with ciprofloxacin, ethambutol and clarithromycin plus non-
steroid anti-inflammatory was started. Four months later, the patient
was in a good clinical condition and the symptoms of lymphadenitis
and the soft tissue abscess resolved (Fig. 1B). At this time, the plasma
viral load was 168 copies/mL (2.23 log10) and the CD4+ T-cell count
was 447 cell/µL (16%).
DISCUSSION
IRIS has been reported for a limited number of patients with various
and previous opportunistic infections and tumors associated with AIDS
immunodeficiency despite the adequate control of virologic and
immunologic parameters5,11,17. IRIS is an inflammatory reaction which
appears after initiating or changing of HAART regimens and is
temporally related with an increase in the CD4+ T-cell counts3,8.
The real incidence of IRIS during HAART is unknown; however,
SHELBURNE et al.18 in a cohort of 180 HIV-infected subjects who
received HAART observed that 31.7% of these patients developed IRIS.
KUMARASAMY et al.9 published an incidence of 15.2 cases/100
patients/year to IRIS related with tuberculosis. NARITA et al.14
published a prevalence of 36% for Mycobacterium tuberculosis-
associated IRIS.
IRIS appears to reflect an immune response against an active
infection by opportunistic pathogens and is associated with delayed-
type hypersensitivity responses to mycobacterial antigens6.
The most frequent manifestations of IRIS published in the medical
literature were MAC lymphadenitis, cytomegalovirus uveitis and
cutaneous herpes zoster18. Major criteria to defining IRIS include the
develop of an opportunistic infection or tumor, including an atypical
presentation, in patients responding to HAART with a reduction of
plasma HIV-RNA level more than one log10 copies/mL, without other
explanation and with evidence of immune restoration, as minor criteria6.
The temporal association between IRIS and the initiation of HAART
has not been well established. PHILLIPS et al.15 reported two patients
with musculoskeletal disease for whom the intervals between HAART
and IRIS were one and two years, respectively. The late onset of IRIS
due to MAC has been described in patients with bone involvement1.
The majority of IRIS cases associated with MAC infections evolve
within the three months after starting HAART. In a large series of 51
patients with IRIS related to nontuberculous mycobacterias, the median
interval from initiation of HAART to the onset of IRIS symptoms was
three weeks (range one to eight weeks), but the median interval since
the onset of symptoms to the diagnostic procedure was 10 weeks (range
six to 19 weeks)15.
Generally, patients with diagnosis of IRIS associated with MAC
presented with inespecific symptoms as fever, fatigue and lymphadenitis
with involvement of major lymph nodes regions: the cervical and
Fig. 1B - After four months of antimycobacterial therapy, the patient presented with neck
scar.
Fig. 1A - Left supraclavicular lymphadenitis as a manifestation of immune reconstitution
inflammatory syndrome (IRIS) due to Mycobacterium avium Complex (MAC) of an HIV-
infected patient.
Fig. 2 - Ultrasound shows a hypoechoic liquid collection compatible with soft tissue abscess
of the right thigh (arrow) of an HIV-infected patient with immune reconstitution inflammatory
syndrome (IRIS).
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supraclavicular regions, the thoracic including the mediastinum and
the abdominal cavity. However, besides the lymphadenitis of different
regions, IRIS associated with MAC and other nontuberculous
mycobacterias include a variety of clinical presentations such as soft
tissue abscesses, monoarthritis, lung cavity, endobronquial lesions,
thoracic and spine mass lesion and MAC bacteremia15. In the PHILLIPS’
serie15, 17 of 51 patients (33%) presented with peripheral
lymphadenopathy; 15 (29%) with pulmonary and thoracic disease and
13 (25%) with abdominal compromise.
Primary or secondary MAC prophylaxis did not protect against
the development of IRIS. PHILLIPS et al.15 published a large series of
nontuberculous mycobacterial IRIS including 51 patients (43 with MAC
infection). Thirty eight (75%) of these patients had no history of
mycobacterial disease.
In this serie15, the median of CD4+ T-cell counts at baseline (pre-
HAART) was 20 cell/µL (range 10 to 50) and the median at IRIS
diagnosis was 120 cell/µL (range 70 to 180). In the same series, the
median of viral load at baseline was 230,000 copies/mL and at the
time of IRIS diagnosis was < 500 copies/mL.
IRIS is an inflammatory syndrome that may cause atypical and
clinical manifestations with a variety of outcomes ranging from
minimal disease to occasionally fatal progression. For example, in a
case published by VENDRELY et al.19 about a patient who presented a
progressive multifocal leucoencephalopathy as a manifestation of IRIS
or in other patients with cryptococosis-associated IRIS13.
Treatment for this complication of AIDS therapy includes the
continuation of primary therapy against the pathogen implicated in
the IRIS to decrease the antigenic load, the continuation of HAART
and, eventually, the use of non-steroid antiinflammatory agents and
corticosteroids8,17. IRIS is a condition thought to be caused by the
improvement in the host’s immune response to several pathogens. IRIS
is common among HIV-infected patients and co-infected with MAC,
Mycobacterium tuberculosis or other pathogens. Diagnosis of IRIS is
difficult for clinicians; differential diagnosis includes treatment failure
or resistance and other opportunistic diseases4,13.
This disorder should be suspected in patients who start HAART in
close proximity to the diagnosis of an opportunistic infection and have
a rapid decline in the HIV viral load and an immune restoration
associated with a rapid increase in the CD4+ T-cell counts.
RESUMEN
Linfadenitis y absceso subcutáneo por Complejo Mycobacterium
avium como manifestación de síndrome inflamatorio de
reconstitución inmune luego de un segundo esquema de terapia
antirretroviral de gran actividad
El síndrome inflamatorio de reconstitución inmune (SIRI) es una
reacción atípica e inesperada relacionada con el tratamiento
antirretroviral de gran actividad (TARGA) en pacientes infectados por
el virus de la inmunodeficiencia humana (VIH). El SIRI representa
una respuesta inflamatoria frente a un patógeno oportunista
(generalmente Mycobacterium tuberculosis, Complejo Mycobacterium
avium, citomegalovirus y herpes varicela-zóster) en pacientes que
responden a la TARGA con una marcada reducción de la carga viral en
plasma y evidencia de una recuperación inmunológica expresada por
el incremento de los niveles de linfocitos T CD4+. Presentamos el caso
de un paciente con síndrome de inmunodeficiencia adquirida que
desarrolló un absceso subcutáneo en muslo derecho y una adenitis
supraclavicular izquierda como manifestación de SIRI por Complejo
Mycobacterium avium luego del inicio de un segundo esquema de
TARGA.
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